![]() This area, the Sassi di Matera, is a complex of cave dwellings carved into the ancient river canyon. 230000015572 biosynthetic process Effects 0.Matera ( Italian pronunciation:, locally ( listen) Materano: Matàrë ) is a city in the region of Basilicata, in Southern Italy.Īs the capital of the province of Matera, its original settlement lies in two canyons carved by the Gravina River.-1 OAc Chemical group 0.000 claims description 36.230000003110 anti-inflammatory Effects 0.000 claims description 37.229940022698 Acetylcholinesterase Drugs 0.000 claims description 43.206010001897 Alzheimer's disease Diseases 0.000 claims description 51.239000000544 cholinesterase inhibitor Substances 0.000 claims abstract description 20.239000000203 mixture Substances 0.000 claims abstract description 30.230000002401 inhibitory effect Effects 0.000 title description 42.102000012440 Acetylcholinesterase Human genes 0.000 title claims 3.239000006186 oral dosage form Substances 0.000 title claims description 8.108010022752 Acetylcholinesterase Proteins 0.000 title claims description 51.239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 6.206010061218 Inflammation Diseases 0.000 title claims abstract description 23.230000004054 inflammatory process Effects 0.000 title claims abstract description 25.206010053643 Neurodegenerative disease Diseases 0.000 title claims abstract description 25.150000001875 compounds Chemical class 0.000 title claims abstract description 112.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to BR102015002132A priority Critical patent/BR102015002132A2/en Priority to BR102015002132-1 priority Application filed by Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig, Universidade Federal Do Rio De Janeiro - Ufrj, Universidade Federal De Alfenas – Unifal-Mg filed Critical Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig Publication of WO2016119031A1 publication Critical patent/WO2016119031A1/en Publication of WO2016119031A8 publication Critical patent/WO2016119031A8/en Links ( en Inventor Eliezer DE JESUS LACERDA BARREIRO Cláudio VIEGAS JÚNIOR Flávio PEREIRA DIAS VIEGAS Miguel DIVINO DA ROCHA Original Assignee Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig Universidade Federal Do Rio De Janeiro - Ufrj Universidade Federal De Alfenas – Unifal-Mg Priority date (The priority date is an assumption and is not a legal conclusion. Rmn matera pdf#Google Patents Compound, method for synthetising the compound, use, pharmaceutical composition, method for treatment of inflammation or neurodegenerative disease, oral dosage form and method for inhibiting the acetylcholinesterase enzymeĭownload PDF Info Publication number WO2016119031A1 WO2016119031A1 PCT/BR2016/050010 BR2016050010W WO2016119031A1 WO 2016119031 A1 WO2016119031 A1 WO 2016119031A1 BR 2016050010 W BR2016050010 W BR 2016050010W WO 2016119031 A1 WO2016119031 A1 WO 2016119031A1 Authority WO WIPO (PCT) Prior art keywords lfqm compound spectrum group disease Prior art date Application number PCT/BR2016/050010 Other languages French ( fr) Google Patents WO2016119031A1 - Compound, method for synthetising the compound, use, pharmaceutical composition, method for treatment of inflammation or neurodegenerative disease, oral dosage form and method for inhibiting the acetylcholinesterase enzyme WO2016119031A1 - Compound, method for synthetising the compound, use, pharmaceutical composition, method for treatment of inflammation or neurodegenerative disease, oral dosage form and method for inhibiting the acetylcholinesterase enzyme ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |